Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Takes Rare Diseases Option from Prosensa

Nov 01 2009

• By Melanie Senior

Related Companies

GSK plc

Prosensa Holding N.V

Leiden University Medical Center

Sirna Therapeutics

Merck & Co., Inc.

Roche Holding AG

Regulus Therapeutics Inc.

Alnylam Pharmaceuticals Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window